Skip to main content
Caplight Logo









Medimaps Group

Medimaps Group

Private
GenevaHealthcare & Life Scienceshttps://www.medimaps.ai/

Last Round

VC Round

Dec 1, 2021

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Medimaps Group is a medical technology company that develops AI-driven imaging software for bone microarchitecture assessment and fracture risk prediction.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

Trabecular Bone ScoreTBSbone microarchitecturemedical imaging AIfracture risk assessmentosteoporosis managementclinical AISoftware as a Medical DeviceSaMDmusculoskeletal AIMSK AIDXA scan analysisbone healthcontract research organizationCROopportunistic screeningSoftware-as-a-DeviceSaaD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medimaps Group Comparables

Compare Medimaps Group with similar companies based on industry and business-model similarity.

Medimaps Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
16 Bit Inc.
84%
3D-Shaper Medical S.L.
83%
ImageBiopsy Lab
82%

Medimaps Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2021

Key People

Founding team and executive leadership

Vincent Zwaans

COO

Executive Team

Medimaps Group Investors

Notable investors and investment history

Medimaps Group investors
InvestorRounds
Verve VenturesVC Round
Swisscom VenturesVC Round
Swiss Entrepreneurs FundVC Round
Swisscanto Private EquityVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors grew 54% MoM, from 3.7K to 5.6K.

  • Feb 25, 2025

    Grew 16% QoQ, from 57 to 66 employees.

Medimaps Group Filings

Explore SEC and related filing metadata, where available.

Medimaps Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medimaps Group's valuation, stock price, and market status.

Is Medimaps Group a public or private company?

Medimaps Group is a private company.

What is the current stock price of Medimaps Group?

Medimaps Group is a private company with no public stock price. Caplight tracks Medimaps Group's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Medimaps Group worth (valuation)?

Valuation information for Medimaps Group is not publicly available.

Can I buy Medimaps Group stock?

Medimaps Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medimaps Group's last funding round?

Medimaps Group's most recent funding round was VC Round on December 1, 2021.

Who are the main investors in Medimaps Group?

Key investors in Medimaps Group include Swisscanto Private Equity.

Will Medimaps Group IPO soon?

No public IPO plans have been announced for Medimaps Group.

How can I track Medimaps Group secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medimaps Group's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGeneva
Employee Range69
Year Founded2012
Last FundingDec 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?